Assessment of leptin and resistin levels in patients with chronic obstructive pulmonary disease

Polskie Archiwum Medycyny Wewnetrznej

Volumn 123, Issue 5, 2013, Pages 215-220

  Kumor Kisielewska, Anna ^a   Kierszniewska Stȩpień, Dorota ^a   Pietras, Tadeusz ^a   Kroczyńska Bednarek, Jadwiga ^a   Kurmanowska, Zofa ^a   Antczak, Adam ^a   Górski, Paweł ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Chronic obstructive pulmonary disease; Leptin; Resistin

Indexed keywords

C REACTIVE PROTEIN; LEPTIN; RESISTIN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; SENSITIVITY AND SPECIFICITY; BLOOD; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; LUNG; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEPTIN; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESISTIN; RESPIRATORY FUNCTION TESTS;

EID: 84880109908     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1724     Document Type: Article

References (23)

1. Nizankowska-Mogilnicka E, Mejza F, Buist A, et al. Prevalence of COPD and tobacco smoking in Malopolska region - results from the BOLD Study in Poland. Pol Arch Med Wewn. 2007; 117: 402-410.
2. Jahnz-Różyk K, Targowski T, From S, et al. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland]. Pneumonol Alergol Pol. 2011; 79: 337-342. Polish.
3. Boros PW, Lubiński W. Health state and the quality of life in patients with chronic obstructive pulmonary disease in Poland: a study using the EuroQoL-5D questionnaire. Pol Arch Med Wewn. 2012; 122: 73-81.
4. Fischer BM, Pavlisko E, Voynow JA. Pathogenic triad in COPD: oxidative stress, protease-antiprotease inbalance, and inflammation. Int J Chron Obstruct Pulmon Dis. 2011; 6: 413-421.
5. Tilemann L, Gindner L, Meyer F, et al. Differences in local and systemic inflammatory markers in patients with obstructive airways disease. Prim Care Respir J. 2011; 20: 407-414.
6. Langereis JD, Schweizer RC, Lammers JW, et al. A unique protein profile of peripheral neutrophils from COPD patients does not reflect cytokine-induced protein profiles of neutrophils in vitro. BMC Pulm Med. 2011; 11: 44.
7. Lainscak M, Von Haehling S, Doehner W, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle. 2011; 2: 81-86.
8. Sood A. Obesity, adipokine, and lung disease. J Appl Physiol. 2010; 108: 744-753.
9. Friedman JM. Obesity in the new millennium. Nature. 2000; 404: 632-634.
10. Unger RH. Leptin physiology: a second look. Regul Pept. 2000; 92: 87-95.
11. Martin SS, Qasim A, Reilly M P. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol. 2008; 52: 1201-1210.
12. Kolasa-Trela R, Miszalski-Jamka T, Grudzień E, et al. Adiponectin, leptin, and resistin in patients with aortic stenosis without concomitant atherosclerotic vascular disease. Pol Arch Med Wewn. 2011; 121: 352-360.
13. Larochelle J, Freiler J, Dice J, et al. Plasma resistin levels in asthmatic as a marker of disease state. J Asthma. 2007; 44: 509-513.
14. Fang C, Meng Q, Wu H, et al. Resistin-like molecule-β is a human airway remodeling mediator. Eur Respir J. 2012; 39: 458-466.
15. Vondracek S F, Voelkel N F, McDermott MT, Valdez C. The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2009; 4: 267-277.
16. Ehtesham NZ, Nasiruddin M, Alvi A, et al. Treatment and point determinants for pulmonary tuberculosis: human resistin as a surrogate biomarker. Tuberculosis (Edinb). 2011; 91: 293-299.
17. Lacoma A, Prat C, Andreo F, et al. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011; 6: 157-169.
18. Kythreotis P, Kokkini A, Aygeropoulou S, et al. Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med. 2009; 5: 9-11.
19. Al Mutairi SS, Mojiminiyi OA, Shihab-Eldeen A, et al. Putative roles of circulating resistin in patients with asthma, COPD, and cigarette smokers. Dis Markers. 2011; 31: 1-7.
20. Poulain M., Doucet M., Drapeau V, et al. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2008; 5: 35-41.
21. Yang YM, Sun TY, Liu XM. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients. Chin Med J (Engl). 2006; 119: 628-633.
22. Breyer MK, Rutten E P, Vernooy JH, et al. Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. Respir Med. 2011; 105: 1046-1053.
23. van den Borst B, Gosker HR, Wesseling G, et al. Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease. Am J Clin Nutr. 2011; 94: 1504-1512.